المؤلفون: Meredith, Luke, Chao, Timothy, Nevler, Avinoam, Mallick, Atrayee Basu, Singla, Rajan, McCue, Peter, Bowne, Wilbur, Jiang, MD, PhD, Wei

المصدر: Kimmel Cancer Center Faculty Papers

مصطلحات موضوعية: humans, male, MTOR inhibitors, mutation, perivascular epithelioid cell neoplasms, sarcoma, sirolimus, TOR serine-threonine kinases, Genomics, Medical Pathology, Oncology, Surgery

وصف الملف: application/pdf

العلاقة: https://jdc.jefferson.edu/kimmelccfp/99Test; https://jdc.jefferson.edu/context/kimmelccfp/article/1099/viewcontent/Rare_Metastatic_Mesenteric_Malignant_PEComa.pdfTest; https://jdc.jefferson.edu/context/kimmelccfp/article/1099/filename/0/type/additional/viewcontent/Supplemental_Figure.docxTest

الإتاحة: https://jdc.jefferson.edu/kimmelccfp/99Test
https://jdc.jefferson.edu/context/kimmelccfp/article/1099/viewcontent/Rare_Metastatic_Mesenteric_Malignant_PEComa.pdfTest
https://jdc.jefferson.edu/context/kimmelccfp/article/1099/filename/0/type/additional/viewcontent/Supplemental_Figure.docxTest

المؤلفون: Alessandra Rünger, Dirk Schadendorf, Axel Hauschild, Christoffer Gebhardt

المصدر: European Journal of Cancer. 175:326-335

مصطلحات موضوعية: Graft Rejection, Cancer Research, Oncology, Neoplasms, TOR Serine-Threonine Kinases, Humans, MTOR Inhibitors, Immune Checkpoint Inhibitors, Immunosuppressive Agents, Transplant Recipients

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e000161ab5212e7067d5282e0682761Test
https://doi.org/10.1016/j.ejca.2022.08.010Test

المؤلفون: Rosemeire Simone Dellacrode Giovanazzi, Walace de Souza Pimentel, João Carlos Marchiori de Claudio, Thulssa Auxiliadora Gomes Medeiros dos Santos, Suelen Alves Creste Martins da Costa, Regimar Carla Machado, Ana Lúcia Gargione Galvão de Sant'Anna, Camila Bomfim von Jakitsch, Nelson Américo Hossne Junior, João Nelson Rodrigues Branco, Puri Girones, Andressa Rodrigues de Souza

المصدر: Transplantation Proceedings. 53:3056-3064

مصطلحات موضوعية: Graft Rejection, Oncology, medicine.medical_specialty, medicine.medical_treatment, Calcineurin Inhibitors, Renal function, law.invention, Randomized controlled trial, law, Internal medicine, medicine, Humans, Lung transplantation, Adverse effect, Sirolimus, Transplantation, Lung, business.industry, TOR Serine-Threonine Kinases, Graft Survival, Immunosuppression, MTOR Inhibitors, Kidney Transplantation, Calcineurin, medicine.anatomical_structure, Meta-analysis, Surgery, business, Immunosuppressive Agents, Lung Transplantation

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96138adbc3c46968892e082ac48c3a82Test
https://doi.org/10.1016/j.transproceed.2021.09.019Test

المؤلفون: Ruud L.M. Bekkers, Phyllis van der Ploeg, Sandrina Lambrechts, Jurgen M.J. Piek, Hans M. Westgeest, Anna M.J. Thijs, Aniek Uittenboogaard, Anja van de Stolpe, Ingrid A. Boere

المساهمون: RS: GROW - R2 - Basic and Translational Cancer Biology, Obstetrie & Gynaecologie, MUMC+: MA Medische Staf Obstetrie Gynaecologie (9)

المصدر: Gynecologic Oncology, 163(2), 433-444. Elsevier Science

مصطلحات موضوعية: Oncology, medicine.medical_treatment, MULTICENTER, Targeted therapy, Phosphatidylinositol 3-Kinases, Clinical endpoint, 1ST-IN-HUMAN, Phosphoinositide-3 Kinase Inhibitors, Ovarian Neoplasms, Mammalian target of rapamycin, PI3K PATHWAY, TOR Serine-Threonine Kinases, MTOR, Obstetrics and Gynecology, MTOR Inhibitors, Signal transduction pathway, Temsirolimus, Treatment Outcome, PHASE-I, ADVANCED SOLID TUMORS, Biomarker (medicine), Female, TRIAL, medicine.drug, Signal Transduction, EPITHELIAL OVARIAN, medicine.medical_specialty, Clinical Decision-Making, Antineoplastic Agents, SDG 3 - Good Health and Well-being, Predictive Value of Tests, Ovarian cancer, Internal medicine, medicine, Biomarkers, Tumor, Humans, DOSE-ESCALATION, Protein kinase B, PI3K/AKT/mTOR pathway, Neoplasm Staging, business.industry, Patient Selection, Akt, medicine.disease, Clinical trial, Phosphatidylinositol-3-kinase, TEMSIROLIMUS, business, Proto-Oncogene Proteins c-akt

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1d4a86c00b11c2413b6be3b738bbee7Test
https://doi.org/10.1016/j.ygyno.2021.07.008Test

المؤلفون: Sandeep Kumar, Shalmoli Bhattacharyya, Ashim Das, Gurpreet Singh, Amanjit Bal

المصدر: Breast disease. 41(1)

مصطلحات موضوعية: Cancer Research, Class I Phosphatidylinositol 3-Kinases, TOR Serine-Threonine Kinases, Breast Neoplasms, Triple Negative Breast Neoplasms, General Medicine, MTOR Inhibitors, Cell Line, Phosphatidylinositol 3-Kinases, Oncology, Receptors, Androgen, Cell Line, Tumor, Humans, Female, skin and connective tissue diseases, Signal Transduction

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56b18720d9547f3d4f20290caa1976caTest
https://pubmed.ncbi.nlm.nih.gov/35431224Test

المؤلفون: Veronica Mollica, Antonio Lopez-Beltran, Francesco Massari, Alessia Cimadamore, Ilaria Maggio, Michelangelo Fiorentino, Eugenio Brunocilla, Liang Cheng, Francesca Giunchi, Riccardo Schiavina, Alessandro Rizzo, Rodolfo Montironi

المساهمون: Mollica V., Maggio I., Lopez-Beltran A., Montironi R., Cimadamore A., Cheng L., Rizzo A., Giunchi F., Schiavina R., Fiorentino M., Brunocilla E., Massari F.

المصدر: Expert Review of Anticancer Therapy. 20:755-763

مصطلحات موضوعية: 0301 basic medicine, Metastatic Urothelial Carcinoma, Combination therapy, Receptor, ErbB-2, Immune checkpoint inhibitors, Poly ADP ribose polymerase, Disease, Poly(ADP-ribose) Polymerase Inhibitors, DDR, PI3K, 03 medical and health sciences, 0302 clinical medicine, Drug Development, Antineoplastic Combined Chemotherapy Protocols, Humans, DNA damage repair, Urothelial cancer, Medicine, Pharmacology (medical), PARP inhibitors, Immune Checkpoint Inhibitors, urothelial carcinoma, PI3K/AKT/mTOR pathway, Neoplasm Staging, Carcinoma, Transitional Cell, business.industry, TOR Serine-Threonine Kinases, HER-2, mTOR, Discovery and development of mTOR inhibitors, PARP inhibitor, 030104 developmental biology, Urinary Bladder Neoplasms, Oncology, 030220 oncology & carcinogenesis, Cancer research, business

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97aeadce830c00f905b74248e83e9037Test
https://doi.org/10.1080/14737140.2020.1807334Test

المؤلفون: David Casadevall, Anna Hernández-Prat, Sara García-Alonso, Oriol Arpí-Llucià, Silvia Menéndez, Mengjuan Qin, Cristina Guardia, Beatriz Morancho, Francisco Javier Sánchez-Martín, Sandra Zazo, Elena Gavilán, Mohammad A. Sabbaghi, Pilar Eroles, Juan Miguel Cejalvo, Ana Lluch, Federico Rojo, Atanasio Pandiella, Ana Rovira, Joan Albanell

المساهمون: Instituto de Salud Carlos III, Generalitat de Catalunya, Ministerio de Economía y Competitividad (España), Fundación CRIS contra el Cáncer, China Scholarship Council, European Commission

المصدر: Digital.CSIC. Repositorio Institucional del CSIC
instname

مصطلحات موضوعية: musculoskeletal diseases, Inhibition of mTOR increases the antitumor activity of T-DM1, congenital, hereditary, and neonatal diseases and abnormalities, Cancer Research, Immunoconjugates, Receptor, ErbB-2, TOR Serine-Threonine Kinases, Breast Neoplasms, Mechanistic Target of Rapamycin Complex 1, Trastuzumab, Ado-Trastuzumab Emtansine, Antibodies, Monoclonal, Humanized, Antibody-drug conjugates warrants clinical evaluation in patients with HER2-positive breast cancer, Xenograft Model Antitumor Assays, Mice, Supporting that the combination of mTOR inhibitors, Oncology, Cell Line, Tumor, Animals, Humans, Female, Everolimus, skin and connective tissue diseases, Molecular Biology

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3656e1cb422ad1d2aa23e9ba81826192Test
http://hdl.handle.net/10261/282954Test

المؤلفون: Sandra Deady, Yvonne Williams, Siona Ni Raghallaigh, Diarmuid D. Houlihan, Donal J. Sexton, Alexander Dudley, Aiden McCormick, Patrick G. Morris, Eamonn O'Leary, Susan L. Murray, Peter J. Conlon, James P. O'Neill, Fergus Daly, Patrick O'Kelly, Nicholas R. Rutledge, Fergal J. Moloney

المصدر: Renal Failure, Vol 42, Iss 1, Pp 607-612 (2020)
Renal Failure
article-version (VoR) Version of Record

مصطلحات موضوعية: Male, Oncology, Skin Neoplasms, medicine.medical_treatment, 030232 urology & nephrology, 030204 cardiovascular system & hematology, lcsh:RC870-923, Critical Care and Intensive Care Medicine, Postoperative Complications, 0302 clinical medicine, Child, Aged, 80 and over, Kidney, immunosuppression, skin cancer, Drug Substitution, Incidence, TOR Serine-Threonine Kinases, Incidence (epidemiology), Immunosuppression, General Medicine, Middle Aged, Discovery and development of mTOR inhibitors, surgical procedures, operative, medicine.anatomical_structure, Nephrology, mtor inhibitor, Female, Immunosuppressive Agents, Research Article, Adult, medicine.medical_specialty, Adolescent, Calcineurin Inhibitors, Renal function, Young Adult, 03 medical and health sciences, Internal medicine, renal transplant, medicine, Humans, cancer, Aged, Retrospective Studies, Sirolimus, business.industry, Cancer, lcsh:Diseases of the genitourinary system. Urology, medicine.disease, Kidney Transplantation, Liver Transplantation, liver transplant, Clinical Study, Skin cancer, business, Ireland, Non melanoma

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c4e1d163b64173d7c43c61a203615f2Test
https://doi.org/10.1080/0886022x.2020.1785499Test

المؤلفون: Ashish Verma, Roli Purwar, Tarun Kumar, Kishan Soni, Manoj Pandey, Mridula Shukla

المصدر: World journal of surgical oncology. 20(1)

مصطلحات موضوعية: business.industry, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Perivascular Epithelioid Cell Neoplasms, TOR Serine-Threonine Kinases, TFE3, Middle Aged, Discovery and development of mTOR inhibitors, Immunohistochemistry, Perivascular Epithelioid Cell, Oncology, Cancer research, Biomarkers, Tumor, Medicine, Humans, Surgery, Female, business, Complete response

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1afa8e3c7bbc942137fd2092e3bbd9eTest
https://pubmed.ncbi.nlm.nih.gov/35232443Test

المؤلفون: Devaraj, Ezhilarasan, Karthik, Shree Harini

المصدر: Oral Oncology. 133:106066

مصطلحات موضوعية: Cancer Research, Oncology, TOR Serine-Threonine Kinases, Humans, Mouth Neoplasms, MTOR Inhibitors, Oral Surgery, Protein Kinase Inhibitors, Phosphoinositide-3 Kinase Inhibitors

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0367fb98423aa3b12485c705675416b4Test
https://doi.org/10.1016/j.oraloncology.2022.106066Test